Elutia Corp (ELUT): Utang-utang marang kapitalisasi buku

Tandha merek Elutia Inc (ELUT)

By adhering to environmental bio-waste disposal regulations, Elutia Inc. demonstrates a minimal carbon footprint. The distribution of debt capital within the balance sheet capitalization, as reflected in GURU.Markets quotes, is characterized by the fact that the 0.74 indicator expresses the state of the metric. The issuer dominates the regenerative medicine sector thanks to CanGaroo antibacterial shells, while generating profit from the sale of bio-implants and surgical drug delivery systems.

ELUT (Elutia Corporation) riwayat Utang marang nilai buku saka 21.02.2024 nganti 27.10.2026
Produk asli Elutia Corporation

The credit quality of the business is determined by the balance between borrowed funds and equity. This metric measures the proportion of liabilities to the total book value of assets, allowing for an assessment of financial stability and the risk of over-leverage. For Elutia Inc. (ELUT), the stability of the liability structure confirms the ability to maintain a costly staff of R&D engineers without excessive debt pressure. An analysis of the company's debt-to-book capitalization reveals the actual dynamics of financial leverage, while this chart filters the trend from market noise.

Karo sapa Elutia Inc. saingan

ISRG - Utang-utang marang kapitalisasi buku|Rasio utang marang nilai buku danaher.com DHR|Utang-utang marang kapitalisasi buku BDX (Becton Dickinson)|STE - Utang-utang marang aset resik|WST (West Pharmaceutical Services Inc) - Utang-utang marang kapitalisasi buku|Baxter Healthcare (BAX) - Utang marang nilai buku|MASI (Masimo Corporation) - Utang-utang marang kapitalisasi buku|Utang-utang marang kapitalisasi buku STVN|Rasio utang marang kapitalisasi buku Teleflex (TFX)|Rasio utang marang kapitalisasi buku Merit Medical Systems, Inc. MMSI|Utang marang nilai buku Envista Holdings Corp|Rasio utang marang aset resik ICU Medical Inc. ICUI|Utang-utang marang kapitalisasi buku XRAY (DENTSPLY SIRONA Inc.)|LMAT: Utang-utang marang aset resik|Rasio utang marang kapitalisasi buku AtriCure|STAA (STAAR Surgical Co.) - Rasio utang marang nilai buku|NAGE: Rasio utang marang kapitalisasi buku|Utang-utang marang aset resik ZimVie Corp (ZIMV)|Utang marang nilai buku AngioDynamics, Inc.|Utang marang modal buku CERS (cerus.com)|Rasio utang marang kapitalisasi buku Teknova|MGRM - Rasio utang marang aset resik|Sharps Tech - Utang marang nilai buku|INFU: Utang-utang marang kapitalisasi buku|UTMD (Utah Medical Products) - Rasio utang marang kapitalisasi buku|KORU Medical (KRMD) - Utang marang nilai buku|Utang-utang marang kapitalisasi buku NYXH (Nyxoah)|Utang-utang marang nilai buku MBOT|Rasio utang marang kapitalisasi buku Pro-Dex Corp PDEX|Rasio utang marang nilai buku Zentek Corp ZTEK|Utang marang nilai buku Milestone Scientific (MLSS)|nexgel.com - Utang marang modal buku|Rasio utang marang kapitalisasi buku RVP (Retractable Tech)|HBIO - Utang-utang marang aset resik|Utang-utang marang kapitalisasi buku FEMY|MHUA (Meihua Medical Technologies Co., Ltd.) - Utang-utang marang nilai buku|Rasio utang marang kapitalisasi buku Predictive Oncology Inc|Rasio utang marang kapitalisasi buku Callan JMB Corp (CJMB)|Utang marang nilai buku ATRI|Utang-utang marang kapitalisasi buku NeuroMetrix Inc NURO